Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; the references it cites are not checked yet.

Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer

Published version of a preprint

Abstract

Emerging evidence has highlighted the host immune system in modulating the patient response to chemotherapy, but the mechanism of this modulation remains unclear. The aim of this study was to analyze the effect of chemotherapy on antitumor immunity in the tumor microenvironment of ovarian cancer. Treatment of ovarian cancer cell lines with various chemotherapeutic agents resulted in upregulated expression of MHC class I and programmed cell death 1 ligand 1 (PD-L1) in a NF-κB-dependent manner and suppression of antigen-specific T-cell function in vitro. In a mouse model of ovarian cancer, treatment with paclitaxel increased CD8(+) T-cell infiltration into the tumor site, upregulated PD-L1 expression, and activated NF-κB signaling. In particular, tumor-bearing mice treated with a combination of paclitaxel and a PD-L1/PD-1 signal blockade survived longer than mice treated with paclitaxel alone. In summary, we found that chemotherapy induces local immune suppression in ovarian cancer through NF-κB-mediated PD-L1 upregulation. Thus, a combination of chemotherapy and immunotherapy targeting the PD-L1/PD-1 signaling axis may improve the antitumor response and offers a promising new treatment modality against ovarian cancer.

Overview

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-14-3098

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Fetching the citation lists

Reading what this paper cites and what cites it from the registries. The lists appear here in a minute or two.

References 52 · Cited by 525

Research works printed but not linked: 1

  1. Carlsson, 2014, PD-L1, Inflammation and Glioblastoma, J Immunol Clin Res, 2, 1013

Metadata

Authors
Peng, J., Hamanishi, J., Matsumura, N., Abiko, K., Murat, K., Baba, T., Yamaguchi, K., Horikawa, N., Hosoe, Y., Murphy, S. K., Konishi, I., & Mandai, M.
Affiliations
  • Kyoto University (JP)
  • Duke University (US)
  • Kindai University (JP)
Venue
Cancer Research
Published
2015-11-30
Volume
75
Issue
23
Pages
5034-5045
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2177804157
Cited by
525
References
52
Citations by year
2026: 19 · 2025: 43 · 2024: 30 · 2023: 57 · 2022: 67 · 2021: 68 · 2020: 68 · 2019: 68 · 2018: 51 · 2017: 32 · 2016: 22
FWCI
15.29
Type
journal article
Language
en
Open access
closed
Locations
  • Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Ono Pharmaceutical
  • Japan Society for the Promotion of Science (26293359, 26670723)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
ovarian cancer, chemotherapy, PD-L1, NF-κB signaling, tumor microenvironment, immunosuppression, MHC class I, paclitaxel, PD-1/PD-L1 blockade, CD8+ T cells, antitumor immunity, combination therapy
MeSH terms
Capecitabine, Docetaxel, Animals, Antineoplastic Combined Chemotherapy Protocols, Female, Humans, Organoplatinum Compounds, Ovarian Neoplasms, NF-kappa B, Xenograft Model Antitumor Assays, Taxoids, Cell Line, Tumor, Mice, Tumor Microenvironment, Transcriptome, B7-H1 Antigen, Programmed Cell Death 1 Receptor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer. https://app.cochat.ai/papers/10.1158/0008-5472.can-14-3098
The paper
Peng, J., Hamanishi, J., Matsumura, N., Abiko, K., Murat, K., Baba, T., Yamaguchi, K., Horikawa, N., Hosoe, Y., Murphy, S. K., Konishi, I., & Mandai, M. (2015). Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer. Cancer Research. https://doi.org/10.1158/0008-5472.can-14-3098

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.